0409-2815 : Precedex 4 ug/ml Intravenous Injection, Solution
NDC: | 0409-2815 |
Labeler: | Hospira, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Precedex |
Dosage Form: | Intravenous Injection, Solution |
Application #: | NDA021038 |
Rev. Date: |
NDC Package Codes:
- 0409-2815-01: 1 BOTTLE IN 1 CARTON (0409‑2815‑01) / 250 ML IN 1 BOTTLE
Active Ingredients:
- Dexmedetomidine Hydrochloride
Dosage Strength:
- 4 ug/mL
Pharmaceutical Classes:
- Adrenergic alpha2-Agonists [MoA]
- Central alpha-2 Adrenergic Agonist [EPC]
- General Anesthesia [PE]
Related Products:
Based on records with the same trade name.- 0409-0155 Precedex 4 ug/ml Intravenous Injection, Solution by Hospira, Inc.
- 0409-1174 Precedex 4 ug/ml Intravenous Injection, Solution by Hospira, Inc.
- 0409-1434 Precedex 4 ug/ml Intravenous Injection, Solution by Hospira, Inc.
- 0409-1454 Precedex 4 ug/ml Intravenous Injection, Solution by Hospira, Inc.
- 0409-1596 Precedex 4 ug/ml Intravenous Injection, Solution by Hospira, Inc.
- 0409-1638 Precedex 100 ug/ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
- 0409-1660 Precedex 4 ug/ml Intravenous Injection, Solution by Hospira, Inc.
- 0409-3301 Precedex 4 ug/ml Intravenous Injection, Solution by Hospira, Inc.
- 0409-4596 Precedex 4 ug/ml Intravenous Injection, Solution by Hospira, Inc.
- 0404-9938 Precedex 100 ug/ml Intravenous Injection, Solution, Concentrate by Henry Schein, Inc.
- 52584-638 Precedex 100 ug/ml Intravenous Injection, Solution, Concentrate by General Injectables and Vaccines, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0409-2776Next: 0409-2987 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.